Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer.

JAMA network open·2026
Same author

Correction: Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays.

Lab on a chip·2026
Same author

Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles".

ACS central science·2026
Same author

X-ray activated platinum complex induces DNA damage and enhances cancer immunotherapy through abscopal effect.

Nature biomedical engineering·2026
Same author

Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates.

Clinical genitourinary cancer·2025
Same author

Multiplexed Nanoparticle Protein Corona Enables Accurate and Precise Deep Plasma Proteomics.

Journal of proteome research·2025

Related Experiment Video

Updated: May 3, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

10.8K

Current progress of aptamer-based molecular imaging.

Andrew Z Wang1, Omid C Farokhzad

  • 1Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, Carolina Center for Cancer Nanotechnology Excellence, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|February 15, 2014
PubMed
Summary
This summary is machine-generated.

Aptamers, or single-stranded oligonucleotides, are versatile molecular targeting ligands. Their unique properties enable successful applications in therapeutics, diagnostics, and molecular imaging.

Keywords:
aptameraptamersmolecular diagnosticsmolecular imaging probes

More Related Videos

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.2K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

6.4K

Related Experiment Videos

Last Updated: May 3, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

10.8K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.2K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

6.4K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medical Imaging

Background:

  • Aptamers are single-stranded oligonucleotides functioning as molecular targeting ligands.
  • These molecules have seen rapid clinical translation since their discovery.
  • Approved aptamer-based therapeutics and diagnostics are already in clinical practice.

Purpose of the Study:

  • To review the advantages of aptamers as targeting ligands.
  • To provide an overview of aptamer applications in molecular imaging.

Main Methods:

  • Literature review of aptamer development and applications.
  • Analysis of aptamer properties relevant to molecular imaging.

Main Results:

  • Aptamers exhibit unique properties suitable for molecular imaging.
  • Established clinical applications in therapeutics and diagnostics highlight their potential.

Conclusions:

  • Aptamers offer significant advantages as targeting ligands in biomedical fields.
  • Their utility is well-suited for advancing molecular imaging techniques.